RT Journal Article
SR Electronic
T1 Oxyphenbutazone eye ointment
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 88
OP 88
DO 10.1136/dtb.22.22.88
VO 22
IS 22
YR 1984
UL http://dtb.bmj.com/content/22/22/88.abstract
AB We have previously considered oxyphenbutazone eye ointment (Tanderil Eye Ointment).1,2 Recently, the Licensing Authority has withdrawn the product licence for oral oxyphenbutazone because of its bone marrow toxicity.3 Oxyphenbutazone eye ointment is used for treating episcleritis: should its licence also be withdrawn?